FDA Removes Marketing Limits on Diabetes Drug Avandia

The FDA, in a U-turn from its position three years ago, removed the restrictions it imposed on the sale of GlaxoSmithKline's diabetes drug Avandia.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news